Skip to main content

METHYLERGONOVINE MALEATE

NDC 51662-1556 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameMETHYLERGONOVINE MALEATE
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)METHYLERGONOVINE MALEATE
Strength.2 mg/mL
Pharmacologic classErgolines [CS], Ergot Derivative [EPC]
Marketing categoryANDA

Packages

51662-1556-2 — 1 AMPULE in 1 POUCH (51662-1556-2) / 1 mL in 1 AMPULE (51662-1556-1)

Billed under HCPCS

J2210 — Injection, methylergonovine maleate, up to 0.2 mg Medicare Part B payment limit (ASP + 6%): $21.55

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0093-3655 — Methylergonovine Maleate, 0517-0740 — Methylergonovine Maleate, 0904-7282 — Methylergonovine Maleate, 16571-735 — Methylergonovine Maleate, 27437-050 — Methylergonovine maleate, 51662-1668 — METHYLERGONOVINE MALEATE, 51991-144 — Methylergonovine Maleate, 60687-813 — Methylergonovine Maleate, 63629-2074 — Methylergonovine Maleate, 63704-004 — methylergonovine maleate, 69238-1605 — Methylergonovine, 70010-786 — Methylergonovine Maleate, 72162-1592 — Methylergonovine Maleate, 83400-100 — Methylergonovine maleate

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels